| Product Code: ETC12568687 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
Despite experiencing a slight decline in growth rate from 2023 to 2024, Israel`s import shipments of long-acting insulin continue to be sourced from a diverse range of top exporting countries such as Switzerland, UK, Belgium, USA, and Germany. The low Herfindahl-Hirschman Index (HHI) concentration indicates a competitive market environment, fostering opportunities for continued market expansion and innovation in the long-acting insulin segment in Israel. The negative Compound Annual Growth Rate (CAGR) from 2020 to 2024 suggests a challenging market landscape, signaling the need for strategic adjustments to drive growth and meet evolving consumer needs.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Long Acting Insulin Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Long Acting Insulin Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Long Acting Insulin Market - Industry Life Cycle |
3.4 Israel Long Acting Insulin Market - Porter's Five Forces |
3.5 Israel Long Acting Insulin Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Israel Long Acting Insulin Market Revenues & Volume Share, By Delivery Method, 2021 & 2031F |
3.7 Israel Long Acting Insulin Market Revenues & Volume Share, By Patient Type, 2021 & 2031F |
3.8 Israel Long Acting Insulin Market Revenues & Volume Share, By Dosage Form, 2021 & 2031F |
4 Israel Long Acting Insulin Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of diabetes in Israel |
4.2.2 Growing awareness about the benefits of long-acting insulin for diabetes management |
4.2.3 Technological advancements in insulin delivery systems |
4.3 Market Restraints |
4.3.1 Stringent regulations and approval processes for new insulin products in Israel |
4.3.2 High cost associated with long-acting insulin therapy |
4.3.3 Limited access to healthcare services in certain regions of Israel |
5 Israel Long Acting Insulin Market Trends |
6 Israel Long Acting Insulin Market, By Types |
6.1 Israel Long Acting Insulin Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Long Acting Insulin Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 Israel Long Acting Insulin Market Revenues & Volume, By Lantus, 2021 - 2031F |
6.1.4 Israel Long Acting Insulin Market Revenues & Volume, By Levemir, 2021 - 2031F |
6.1.5 Israel Long Acting Insulin Market Revenues & Volume, By Tresiba, 2021 - 2031F |
6.1.6 Israel Long Acting Insulin Market Revenues & Volume, By Basaglar, 2021 - 2031F |
6.1.7 Israel Long Acting Insulin Market Revenues & Volume, By Toujeo, 2021 - 2031F |
6.2 Israel Long Acting Insulin Market, By Delivery Method |
6.2.1 Overview and Analysis |
6.2.2 Israel Long Acting Insulin Market Revenues & Volume, By Pen, 2021 - 2031F |
6.2.3 Israel Long Acting Insulin Market Revenues & Volume, By Syringe, 2021 - 2031F |
6.2.4 Israel Long Acting Insulin Market Revenues & Volume, By Pump, 2021 - 2031F |
6.2.5 Israel Long Acting Insulin Market Revenues & Volume, By Pre-filled Device, 2021 - 2031F |
6.3 Israel Long Acting Insulin Market, By Patient Type |
6.3.1 Overview and Analysis |
6.3.2 Israel Long Acting Insulin Market Revenues & Volume, By Type 1 Diabetes, 2021 - 2031F |
6.3.3 Israel Long Acting Insulin Market Revenues & Volume, By Type 2 Diabetes, 2021 - 2031F |
6.3.4 Israel Long Acting Insulin Market Revenues & Volume, By Gestational Diabetes, 2021 - 2031F |
6.4 Israel Long Acting Insulin Market, By Dosage Form |
6.4.1 Overview and Analysis |
6.4.2 Israel Long Acting Insulin Market Revenues & Volume, By Solution, 2021 - 2031F |
6.4.3 Israel Long Acting Insulin Market Revenues & Volume, By Suspension, 2021 - 2031F |
7 Israel Long Acting Insulin Market Import-Export Trade Statistics |
7.1 Israel Long Acting Insulin Market Export to Major Countries |
7.2 Israel Long Acting Insulin Market Imports from Major Countries |
8 Israel Long Acting Insulin Market Key Performance Indicators |
8.1 Percentage of diabetic population in Israel using long-acting insulin |
8.2 Adoption rate of long-acting insulin compared to traditional insulin therapy |
8.3 Patient satisfaction and adherence rates with long-acting insulin treatment |
8.4 Rate of technological adoption in insulin delivery systems in Israel |
8.5 Number of clinical trials and research studies on long-acting insulin conducted in Israel |
9 Israel Long Acting Insulin Market - Opportunity Assessment |
9.1 Israel Long Acting Insulin Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Israel Long Acting Insulin Market Opportunity Assessment, By Delivery Method, 2021 & 2031F |
9.3 Israel Long Acting Insulin Market Opportunity Assessment, By Patient Type, 2021 & 2031F |
9.4 Israel Long Acting Insulin Market Opportunity Assessment, By Dosage Form, 2021 & 2031F |
10 Israel Long Acting Insulin Market - Competitive Landscape |
10.1 Israel Long Acting Insulin Market Revenue Share, By Companies, 2024 |
10.2 Israel Long Acting Insulin Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here